Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paroxysmal Arrhythmia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05144503
What this trial is testing

Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions 100
Not applicableWithdrawnNCT04600713
What this trial is testing

Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.

Who this might be right for
Atrial Fibrillation Paroxysmal
Vastra Gotaland Region
Large-scale testing (Phase 3)Ended earlyNCT00721149
What this trial is testing

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study

Who this might be right for
Heart DiseasesArrhythmiaAtrial Fibrillation
Biosense Webster, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01185613
What this trial is testing

Clinical Evaluation of Therapy™ Cool Flex Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
Abbott Medical Devices 50
Not applicableUnknownNCT05911685
What this trial is testing

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Who this might be right for
Atrial Fibrillation
Hangzhou Dinova EP Technology Co., Ltd 163
Post-approval studies (Phase 4)Study completedNCT00189319
What this trial is testing

To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
MEDA Pharma GmbH & Co. KG 200
Post-approval studies (Phase 4)Active Not RecruitingNCT06765356
What this trial is testing

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

Who this might be right for
Persistent Atrial FibrillationParoxysmal Atrial FibrillationLong-standing Persistent Atrial Fibrillation
Vivek Reddy 275
Not applicableUnknownNCT02791022
What this trial is testing

Singapore Atrial Fibrillation Study

Who this might be right for
Atrial Fibrillation
National Heart Centre Singapore 2,500
Not applicableLooking for participantsNCT07298473
What this trial is testing

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Who this might be right for
Atrial Fibrillation (AF)Persistent Atrial FibrillationParoxysmal Atrial Fibrillation (PAF)
Medtronic Cardiac Ablation Solutions 400
Not applicableLooking for participantsNCT05115214
What this trial is testing

Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions 150
Not applicableActive Not RecruitingNCT07308847
What this trial is testing

Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)

Who this might be right for
Paroxysmal AF
Medtronic Cardiac Ablation Solutions 300
Testing effectiveness (Phase 2)Study completedNCT00971204
What this trial is testing

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
CardioFocus 100
Post-approval studies (Phase 4)Study completedNCT03005366
What this trial is testing

Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents

Who this might be right for
Paroxysmal Atrial Fibrillation
David Filgueiras-Rama 50
Not applicableNot Yet RecruitingNCT07068646
What this trial is testing

Thickness Map-Guided vs. Empirical PV Isolation Using Pulsed Field Ablation for Paroxysmal AF

Who this might be right for
Atrial Fibrillation
Yonsei University 298
Not applicableEnded earlyNCT01683045
What this trial is testing

Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats

Who this might be right for
Persistent Atrial Fibrillation
Endoscopic Technologies, Inc 6
Testing effectiveness (Phase 2)Study completedNCT03539302
What this trial is testing

INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Who this might be right for
Paroxysmal Atrial Fibrillation (PAF)
InCarda Therapeutics, Inc. 176
Not applicableActive Not RecruitingNCT06106594
What this trial is testing

VOLT CE Mark Study

Who this might be right for
Atrial ArrhythmiaAtrial FibrillationParoxysmal Atrial Fibrillation+1 more
Abbott Medical Devices 300
Large-scale testing (Phase 3)Study completedNCT01385202
What this trial is testing

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Who this might be right for
Heart DiseasesArrhythmiaAtrial Fibrillation
Biosense Webster, Inc. 172
Not applicableStudy completedNCT01325675
What this trial is testing

Aerobic Interval Training in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Norwegian University of Science and Technology 51
Not applicableUnknownNCT05179902
What this trial is testing

Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation

Who this might be right for
Women and Men Over 18 Years OldAF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AFAble to Give His Non Opposition to Participate to the Study
University Hospital, Clermont-Ferrand 190
Next Page